Faculty profile

Nicole Bernard

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Nicole Bernard

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2021.
Principal investigator on 6 research grants (6 CIHR), most recently in 2016.
Supervised 7 trainees who won CIHR awards, most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Nk Cells Hiv/Aids Antibody Dependent Cellular Cytotoxicity Correlates Of Protection From Infection Hla Immune Function Killer Immunoglobulin-Like Receptors Nk Receptors

Latest papers

Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction.
Frontiers in immunology · 2021
KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort.
AIDS (London, England) · 2018
The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
BMC infectious diseases · 2017

All 12 publications

Latest funding

Antiretroviral-based HIV prevention and its impact on sexual risk behaviours and HIV/STIs among gay, bisexual and other men who have sex with men: Engage Cohort Study
CIHR · 2018 · Co-investigator
$2,673,676
Locking out HIV from CD4 T cells: A pilot study of the impact of anti a4b7 antibody (vedolizumab) on viral control following analytical treatment interruption
CIHR · 2017 · Co-investigator
$247,650
Investigation of the role of HIV-Envelope specific antibody dependent innate immune cell functionality in HIV control.
CIHR · 2016 · Nominated PI
$764,500

All 18 grants and awards

12 publications.

Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction.

Bunet R, Nayrac M, Ramani H, Sylla M, Durand M, Chartrand-Lefebvre C, Routy JP, Landay AL, Gauchat JF, Chomont N, Ancuta P, Kaufmann DE, Bernard N, Tremblay CL, El-Far M

Frontiers in immunology2021

DOI: 10.3389/fimmu.2021.673061 PMID: 34122431

KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort.

Luo M, Czarnecki C, Nebroski M, Kimani J, Bernard N, Plummer FA

AIDS (London, England)2018

DOI: 10.1097/qad.0000000000001735 PMID: 29280757

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.

Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, Abrahamowicz M, Zhu Z, Tsoukas C, Ancuta P, Bernard N, Tremblay CL, investigators of the Canadian HIV and Aging Cohort Study

BMC infectious diseases2017

DOI: 10.1186/s12879-017-2692-2 PMID: 28893184

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.

El-Far M, Kouassi P, Sylla M, Zhang Y, Fouda A, Fabre T, Goulet JP, van Grevenynghe J, Lee T, Singer J, Harris M, Baril JG, Trottier B, Ancuta P, Routy JP, Bernard N, Tremblay CL, Investigators of the Canadian HIV+ Slow Progressor Cohort

Scientific reports2016

DOI: 10.1038/srep22902 PMID: 26978598

Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.

DaFonseca S, Niessl J, Pouvreau S, Wacleche VS, Gosselin A, Cleret-Buhot A, Bernard N, Tremblay C, Jenabian MA, Routy JP, Ancuta P

Retrovirology2015

DOI: 10.1186/s12977-015-0164-6 PMID: 25924895

The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.

Olvera A, Pérez-Álvarez S, Ibarrondo J, Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N, Gomez L, Sanchez J, Brander C

AIDS (London, England)2015

DOI: 10.1097/qad.0000000000000574 PMID: 25715101

The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals.

Veillette M, Coutu M, Richard J, Batraville LA, Dagher O, Bernard N, Tremblay C, Kaufmann DE, Roger M, Finzi A

Journal of virology2015

DOI: 10.1128/jvi.02868-14 PMID: 25339767

Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses.

Richard J, Veillette M, Batraville LA, Coutu M, Chapleau JP, Bonsignori M, Bernard N, Tremblay C, Roger M, Kaufmann DE, Finzi A

Journal of virological methods2014

DOI: 10.1016/j.jviromet.2014.08.003 PMID: 25125129

eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection.

Valiente-Echeverría F, Melnychuk L, Vyboh K, Ajamian L, Gallouzi IE, Bernard N, Mouland AJ

Nature communications2014

DOI: 10.1038/ncomms5819 PMID: 25229650

CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction.

Peretz Y, He Z, Shi Y, Yassine-Diab B, Goulet JP, Bordi R, Filali-Mouhim A, Loubert JB, El-Far M, Dupuy FP, Boulassel MR, Tremblay C, Routy JP, Bernard N, Balderas R, Haddad EK, Sékaly RP

PLoS pathogens2012

DOI: 10.1371/journal.ppat.1002840 PMID: 22916009

Something wrong or missing on this profile? Suggest a correction

Nicole Bernard

Research

Latest papers

Latest funding

Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction.

KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort.

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.

Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.

The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.

The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals.

Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses.

eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection.

CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction.

Frequent collaborators

Nicole Bernard

Jean-Pierre Routy

Jean-Pierre Routy

Petronela Ancuta

Michel Roger

Mohammad-Ali Jenabian

Nicolas Chomont

Sharon Walmsley

Mohammad-Ali Jenabian

Joshua Kimani

Mohammad-Ali Jenabian

Christos Tsoukas

Nicolas Chomont

George Thanassoulis

Michal Abrahamowicz

Christos Tsoukas

Ma Luo